K74.01
Hepatic fibrosis, early fibrosis
Clinical Classification Guidelines
Inclusion Terms
- Hepatic fibrosis, stage F1 or stage F2
Medical Intelligence & Overview
Hepatic fibrosis refers to the early scarring of the liver tissue due to ongoing liver injury or inflammation. When fibrosis is in its initial stages, known as early fibrosis, it is often asymptomatic and may be reversible if the underlying cause is addressed. Under ICD-10 classification, this condition is identified by code K74.01, indicating fibrosis at stages F1 and F2. Recognizing and understanding this stage of liver scarring is important for preventing progression to more severe liver damage, such as cirrhosis.
Causes & Symptoms
Clinical Causes: Chronic alcohol consumption Viral hepatitis (especially B and C) Non-alcoholic fatty liver disease (NAFLD) Autoimmune liver diseases Certain inherited liver conditions Long-term exposure to toxins or medications Metabolic disorders such as hemochromatosis or Wilson's disease
Key Symptoms: Often no noticeable symptoms in early stages Mild fatigue Unexplained weight loss Discomfort or a dull ache in the upper right abdomen Elevated liver enzymes detected during routine blood tests
Diagnostic & Treatment
Diagnosis Path: Diagnosis of early hepatic fibrosis typically involves a combination of clinical assessment, blood tests, imaging studies, and sometimes liver biopsy. Blood tests may reveal abnormal liver function indicators, while imaging methods like elastography or MRI elastography can assess liver stiffness. A definitive diagnosis might require a liver biopsy, which allows direct examination of liver tissue for fibrosis staging.
Treatment Protocols: Treatment focuses on managing the underlying cause of liver injury to halt or reverse the fibrosis process. Recommendations often include:
Clinical Advice & FAQs
Billing Guidance
Is K74.01 a billable ICD-10 code?
Yes, K74.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K74.01?
Clinical documentation must specify the nature of Hepatic fibrosis, early fibrosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference